Related Experiment Video
Updated: Jun 24, 2026

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Neuroleptic malignant syndrome associated with severe thrombocytopenia
1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Abstract:
The case of a 32-year-old woman with neuroleptic malignant syndrome and severe haemorrhagic thrombocytopenia is presented. Detailed investigations were negative, and the thrombocytopenia resolved along with her fever, obtundation, autonomic instability and oculogyric crisis. No prior similar cases have been described in the literature. A discussion of neuroleptic malignant syndrome and neuroleptic-related thrombocytopenia follows, in addition to the possible mechanisms of the thrombocytopenia in this case.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Tetanus
Diphtheria